WHO lists mpox vaccine by Japan's KM Biologics for emergency use
The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to ...
Bayer acquires rights to Cytokinetics' heart drug in Japan
Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular ...